0
0
40 words
0
Comments
The FDA requested that Novo take immediate action to address the violations, which could include ceasing all ads containing misleading claims about the pill.
You are the first to view
https://www.cnbc.com/2026/02/09/fda-novo-nordisk-wegovy-tv-ad.html
Create an account or login to join the discussion